CTI BioPharma Corp. Made Big Gain
Tue, Mar 01, 2022 at 05:30 PM
CTI BioPharma Corp. (CTIC:NASDAQ) shot up at $3.1, representing a gain of 63.2%. On Mon, Feb 28, 2022, CTIC:NASDAQ touched a New 2-Week Low of $1.9. The stock appeared on our News Catalysts scanner on Mon, Feb 28, 2022 at 08:48 PM in the 'BIOTECH' category. From Mon, Feb 14, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Fri, Dec 31, 2021 at $2.54 with a volume of 1M+.
About CTI BioPharma Corp. (CTIC:NASDAQ)
CTI BioPharma Corp is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of novel targeted therapies.
Top 10 Gainers:
- Viscogliosi Brothers Acquisition Corp (VBOC:NASDAQ), 100%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 78.46%
- CTI BioPharma Corp. (CTIC:NASDAQ), 63.16%
- GBS Inc. (GBS:NASDAQ), 50%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 47.84%
- CooTek (Cayman) Inc. (CTK:NYSE), 36.24%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 36.11%
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 30.84%
- GWG Holdings, Inc. (GWGH:NASDAQ), 29.37%
- Avinger, Inc. (AVGR:NASDAQ), 28.31%